$143.96
1.73% yesterday
Nasdaq, Nov 26, 10:00 pm CET

Masimo Corporation Stock price

$143.96
-4.04 2.73% 1M
-6.17 4.11% 6M
-21.34 12.91% YTD
-28.30 16.43% 1Y
+2.00 1.41% 3Y
-101.45 41.34% 5Y
+101.73 240.90% 10Y
+125.84 694.55% 20Y
Nasdaq, Closing price Wed, Nov 26 2025
-2.53 1.73%

New AI Insights on Masimo Corporation Insights AI Insights on Masimo Corporation

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$7.7b
Enterprise Value
$8.0b
Net debt
$246.8m
Cash
$312.3m
Shares outstanding
53.1m
Valuation (TTM | estimate)
P/E
negative | 26.5
P/S
4.5 | 5.0
EV/Sales
4.7 | 5.1
EV/FCF
42.3
P/B
9.6
Financial Health
Equity Ratio
40.1%
Return on Equity
-29.0%
ROCE
12.2%
ROIC
17.1%
Debt/Equity
0.7
Financials (TTM | estimate)
Revenue
$1.7b | $1.6b
EBITDA
$232.4m | $476.9m
EBIT
$176.4m | $423.7m
Net Income
$-569.4m | $288.9m
Free Cash Flow
$188.7m
Growth (TTM | estimate)
Revenue
-16.0% | -26.0%
EBITDA
-9.1% | 224.8%
EBIT
9.5% | 867.4%
Net Income
-824.4% | 194.8%
Free Cash Flow
26.1%
Margin (TTM | estimate)
Gross
55.0%
EBITDA
13.6% | 30.7%
EBIT
10.3%
Net
-33.2% | 18.6%
Free Cash Flow
11.0%
More
EPS
$-10.5
FCF per Share
$3.6
Short interest
10.4%
Employees
4k
Rev per Employee
$580.0k
Show more

Is Masimo Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,049 stocks worldwide.

Masimo Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Masimo Corporation forecast:

12x Buy
80%
3x Hold
20%

Analyst Opinions

15 Analysts have issued a Masimo Corporation forecast:

Buy
80%
Hold
20%

Financial data from Masimo Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,715 1,715
16% 16%
100%
- Direct Costs 773 773
24% 24%
45%
943 943
8% 8%
55%
- Selling and Administrative Expenses 594 594
12% 12%
35%
- Research and Development Expense 172 172
6% 6%
10%
232 232
9% 9%
14%
- Depreciation and Amortization 56 56
41% 41%
3%
EBIT (Operating Income) EBIT 176 176
9% 9%
10%
Net Profit -569 -569
824% 824%
-33%

In millions USD.

Don't miss a Thing! We will send you all news about Masimo Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Masimo Corporation Stock News

Neutral
PRNewsWire
9 days ago
IRVINE, Calif. , Nov. 18, 2025 /PRNewswire/ -- A team from Knobbe Martens led medical device pioneer Masimo (NASDAQ: MASI) to a victory over Apple in a dispute involving Masimo's patented heart monitoring technology.
Neutral
GlobeNewsWire
10 days ago
DRC congratulates Knobbe Martens on a decisive jury verdict awarding its client Masimo more than $634 million in an Apple Watch patent infringement case.
Negative
The Motley Fool
11 days ago
Sold 45,000 shares in Masimo, reducing reported position by $7,569,900 Transaction represents a 4.0301% change in 13F reportable assets under management (AUM) Post-trade stake: 0 shares, $0 reported value The position was previously 4.0699% of the fund's AUM as of the prior quarter, marking a full exit this period
More Masimo Corporation News

Company Profile

Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.

Head office United States
CEO Catherine Szyman
Employees 3,600
Founded 1989
Website www.masimo.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today